Loomba Rohit, Friedman Scott L, Shulman Gerald I
NAFLD Research Center, Division of Gastroenterology, Department of Medicine, University of California at San Diego, La Jolla, CA 92093, USA.
Division of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Cell. 2021 May 13;184(10):2537-2564. doi: 10.1016/j.cell.2021.04.015.
Nonalcoholic fatty liver disease (NAFLD) is the leading chronic liver disease worldwide. Its more advanced subtype, nonalcoholic steatohepatitis (NASH), connotes progressive liver injury that can lead to cirrhosis and hepatocellular carcinoma. Here we provide an in-depth discussion of the underlying pathogenetic mechanisms that lead to progressive liver injury, including the metabolic origins of NAFLD, the effect of NAFLD on hepatic glucose and lipid metabolism, bile acid toxicity, macrophage dysfunction, and hepatic stellate cell activation, and consider the role of genetic, epigenetic, and environmental factors that promote fibrosis progression and risk of hepatocellular carcinoma in NASH.
非酒精性脂肪性肝病(NAFLD)是全球主要的慢性肝病。其更严重的亚型非酒精性脂肪性肝炎(NASH)意味着会导致进行性肝损伤,进而可发展为肝硬化和肝细胞癌。在此,我们深入探讨导致进行性肝损伤的潜在发病机制,包括NAFLD的代谢起源、NAFLD对肝脏葡萄糖和脂质代谢的影响、胆汁酸毒性、巨噬细胞功能障碍以及肝星状细胞活化,并考量遗传、表观遗传和环境因素在促进NASH纤维化进展及肝细胞癌风险方面的作用。